HEALTHSTREAM INC (HSTM) Fundamental Analysis & Valuation

NASDAQ:HSTM • US42222N1037

Current stock price

20.9 USD
-0.59 (-2.75%)
At close:
20.9 USD
0 (0%)
After Hours:

This HSTM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. HSTM Profitability Analysis

1.1 Basic Checks

  • In the past year HSTM was profitable.
  • HSTM had a positive operating cash flow in the past year.
  • In the past 5 years HSTM has always been profitable.
  • HSTM had a positive operating cash flow in each of the past 5 years.
HSTM Yearly Net Income VS EBIT VS OCF VS FCFHSTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 3.52%, HSTM belongs to the top of the industry, outperforming 82.86% of the companies in the same industry.
  • HSTM has a better Return On Equity (5.18%) than 82.86% of its industry peers.
  • HSTM has a Return On Invested Capital of 4.08%. This is in the better half of the industry: HSTM outperforms 77.14% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for HSTM is below the industry average of 7.46%.
  • The 3 year average ROIC (3.91%) for HSTM is below the current ROIC(4.08%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.52%
ROE 5.18%
ROIC 4.08%
ROA(3y)3.49%
ROA(5y)2.82%
ROE(3y)5.07%
ROE(5y)4.11%
ROIC(3y)3.91%
ROIC(5y)3.2%
HSTM Yearly ROA, ROE, ROICHSTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • The Profit Margin of HSTM (6.03%) is better than 91.43% of its industry peers.
  • In the last couple of years the Profit Margin of HSTM has remained more or less at the same level.
  • HSTM has a better Operating Margin (6.65%) than 77.14% of its industry peers.
  • HSTM's Operating Margin has been stable in the last couple of years.
  • HSTM has a Gross Margin (64.74%) which is comparable to the rest of the industry.
  • HSTM's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.65%
PM (TTM) 6.03%
GM 64.74%
OM growth 3Y12.71%
OM growth 5Y0.62%
PM growth 3Y9.98%
PM growth 5Y0.93%
GM growth 3Y-0.57%
GM growth 5Y0.38%
HSTM Yearly Profit, Operating, Gross MarginsHSTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. HSTM Health Analysis

2.1 Basic Checks

  • HSTM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for HSTM has been reduced compared to 1 year ago.
  • HSTM has less shares outstanding than it did 5 years ago.
  • There is no outstanding debt for HSTM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
HSTM Yearly Shares OutstandingHSTM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
HSTM Yearly Total Debt VS Total AssetsHSTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

  • An Altman-Z score of 3.24 indicates that HSTM is not in any danger for bankruptcy at the moment.
  • HSTM has a better Altman-Z score (3.24) than 77.14% of its industry peers.
  • HSTM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.24
ROIC/WACC0.45
WACC9%
HSTM Yearly LT Debt VS Equity VS FCFHSTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 0.96 indicates that HSTM may have some problems paying its short term obligations.
  • The Current ratio of HSTM (0.96) is worse than 85.71% of its industry peers.
  • A Quick Ratio of 0.96 indicates that HSTM may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.96, HSTM is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.96
Quick Ratio 0.96
HSTM Yearly Current Assets VS Current LiabilitesHSTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. HSTM Growth Analysis

3.1 Past

  • HSTM shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.06%.
  • The Earnings Per Share has been growing by 16.23% on average over the past years. This is quite good.
  • HSTM shows a small growth in Revenue. In the last year, the Revenue has grown by 4.26%.
  • HSTM shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.43% yearly.
EPS 1Y (TTM)6.06%
EPS 3Y21.53%
EPS 5Y16.23%
EPS Q2Q%12.5%
Revenue 1Y (TTM)4.26%
Revenue growth 3Y4.45%
Revenue growth 5Y4.43%
Sales Q2Q%7.37%

3.2 Future

  • HSTM is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.31% yearly.
  • HSTM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.81% yearly.
EPS Next Y6.66%
EPS Next 2Y9.31%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.55%
Revenue Next 2Y6.82%
Revenue Next 3Y4.19%
Revenue Next 5Y4.81%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
HSTM Yearly Revenue VS EstimatesHSTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M
HSTM Yearly EPS VS EstimatesHSTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8

More info and screens

Find the best growth stocksShow best growing peers

4

4. HSTM Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 29.86 indicates a quite expensive valuation of HSTM.
  • Compared to the rest of the industry, the Price/Earnings ratio of HSTM indicates a somewhat cheap valuation: HSTM is cheaper than 71.43% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of HSTM to the average of the S&P500 Index (27.47), we can say HSTM is valued inline with the index average.
  • A Price/Forward Earnings ratio of 27.99 indicates a quite expensive valuation of HSTM.
  • HSTM's Price/Forward Earnings ratio is in line with the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 22.62. HSTM is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 29.86
Fwd PE 27.99
HSTM Price Earnings VS Forward Price EarningsHSTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, HSTM is valued cheaply inside the industry as 82.86% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of HSTM indicates a somewhat cheap valuation: HSTM is cheaper than 65.71% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 19.66
EV/EBITDA 8.39
HSTM Per share dataHSTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The decent profitability rating of HSTM may justify a higher PE ratio.
PEG (NY)4.48
PEG (5Y)1.84
EPS Next 2Y9.31%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. HSTM Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.60%, HSTM is not a good candidate for dividend investing.
  • HSTM's Dividend Yield is rather good when compared to the industry average which is at 0.57. HSTM pays more dividend than 91.43% of the companies in the same industry.
  • With a Dividend Yield of 0.60, HSTM pays less dividend than the S&P500 average, which is at 1.81.
Industry RankSector Rank
Dividend Yield 0.6%

5.2 History

  • On average, the dividend of HSTM grows each year by 148.95%, which is quite nice.
  • HSTM has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)148.95%
Div Incr Years2
Div Non Decr Years2
HSTM Yearly Dividends per shareHSTM Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 2026 0.02 0.04 0.06 0.08 0.1

5.3 Sustainability

  • HSTM pays out 20.33% of its income as dividend. This is a sustainable payout ratio.
  • HSTM's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP20.33%
EPS Next 2Y9.31%
EPS Next 3YN/A
HSTM Yearly Income VS Free CF VS DividendHSTM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
HSTM Dividend Payout.HSTM Dividend Payout, showing the Payout Ratio.HSTM Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

HSTM Fundamentals: All Metrics, Ratios and Statistics

HEALTHSTREAM INC

NASDAQ:HSTM (4/23/2026, 8:16:26 PM)

After market: 20.9 0 (0%)

20.9

-0.59 (-2.75%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)02-23
Earnings (Next)04-27
Inst Owners74.13%
Inst Owner Change-0.15%
Ins Owners17.27%
Ins Owner Change-21.88%
Market Cap612.58M
Revenue(TTM)304.06M
Net Income(TTM)18.34M
Analysts78.18
Price Target21.42 (2.49%)
Short Float %3.73%
Short Ratio2.53
Dividend
Industry RankSector Rank
Dividend Yield 0.6%
Yearly Dividend0.12
Dividend Growth(5Y)148.95%
DP20.33%
Div Incr Years2
Div Non Decr Years2
Ex-Date03-09
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)35.92%
Min EPS beat(2)11.41%
Max EPS beat(2)60.43%
EPS beat(4)3
Avg EPS beat(4)18.24%
Min EPS beat(4)-12.02%
Max EPS beat(4)60.43%
EPS beat(8)7
Avg EPS beat(8)25.3%
EPS beat(12)11
Avg EPS beat(12)29.71%
EPS beat(16)15
Avg EPS beat(16)53.52%
Revenue beat(2)1
Avg Revenue beat(2)0.91%
Min Revenue beat(2)-0.73%
Max Revenue beat(2)2.56%
Revenue beat(4)1
Avg Revenue beat(4)-1%
Min Revenue beat(4)-3.85%
Max Revenue beat(4)2.56%
Revenue beat(8)1
Avg Revenue beat(8)-1.5%
Revenue beat(12)1
Avg Revenue beat(12)-1.71%
Revenue beat(16)1
Avg Revenue beat(16)-1.92%
PT rev (1m)-35.38%
PT rev (3m)-35.38%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-7.14%
EPS NY rev (1m)-2.4%
EPS NY rev (3m)-3.68%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.49%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.49%
Valuation
Industry RankSector Rank
PE 29.86
Fwd PE 27.99
P/S 2.01
P/FCF 19.66
P/OCF 9.67
P/B 1.73
P/tB 23.57
EV/EBITDA 8.39
EPS(TTM)0.7
EY3.35%
EPS(NY)0.75
Fwd EY3.57%
FCF(TTM)1.06
FCFY5.09%
OCF(TTM)2.16
OCFY10.34%
SpS10.37
BVpS12.08
TBVpS0.89
PEG (NY)4.48
PEG (5Y)1.84
Graham Number13.7927 (-34.01%)
Profitability
Industry RankSector Rank
ROA 3.52%
ROE 5.18%
ROCE 5.11%
ROIC 4.08%
ROICexc 4.76%
ROICexgc 144.29%
OM 6.65%
PM (TTM) 6.03%
GM 64.74%
FCFM 10.25%
ROA(3y)3.49%
ROA(5y)2.82%
ROE(3y)5.07%
ROE(5y)4.11%
ROIC(3y)3.91%
ROIC(5y)3.2%
ROICexc(3y)4.86%
ROICexc(5y)3.91%
ROICexgc(3y)162.5%
ROICexgc(5y)114.53%
ROCE(3y)4.9%
ROCE(5y)4.01%
ROICexgc growth 3Y31.22%
ROICexgc growth 5Y26.84%
ROICexc growth 3Y16.25%
ROICexc growth 5Y4.77%
OM growth 3Y12.71%
OM growth 5Y0.62%
PM growth 3Y9.98%
PM growth 5Y0.93%
GM growth 3Y-0.57%
GM growth 5Y0.38%
F-Score6
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 73.98%
Cap/Sales 10.58%
Interest Coverage 200.35
Cash Conversion 99.38%
Profit Quality 169.87%
Current Ratio 0.96
Quick Ratio 0.96
Altman-Z 3.24
F-Score6
WACC9%
ROIC/WACC0.45
Cap/Depr(3y)70.13%
Cap/Depr(5y)69.08%
Cap/Sales(3y)10.09%
Cap/Sales(5y)9.91%
Profit Quality(3y)184.6%
Profit Quality(5y)212.64%
High Growth Momentum
Growth
EPS 1Y (TTM)6.06%
EPS 3Y21.53%
EPS 5Y16.23%
EPS Q2Q%12.5%
EPS Next Y6.66%
EPS Next 2Y9.31%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.26%
Revenue growth 3Y4.45%
Revenue growth 5Y4.43%
Sales Q2Q%7.37%
Revenue Next Year8.55%
Revenue Next 2Y6.82%
Revenue Next 3Y4.19%
Revenue Next 5Y4.81%
EBIT growth 1Y-4.95%
EBIT growth 3Y17.73%
EBIT growth 5Y5.07%
EBIT Next Year261.77%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y5.55%
FCF growth 3Y6.09%
FCF growth 5Y12.79%
OCF growth 1Y9.81%
OCF growth 3Y7.35%
OCF growth 5Y12.04%

HEALTHSTREAM INC / HSTM Fundamental Analysis FAQ

What is the fundamental rating for HSTM stock?

ChartMill assigns a fundamental rating of 5 / 10 to HSTM.


What is the valuation status for HSTM stock?

ChartMill assigns a valuation rating of 4 / 10 to HEALTHSTREAM INC (HSTM). This can be considered as Fairly Valued.


How profitable is HEALTHSTREAM INC (HSTM) stock?

HEALTHSTREAM INC (HSTM) has a profitability rating of 7 / 10.


What is the valuation of HEALTHSTREAM INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for HEALTHSTREAM INC (HSTM) is 29.86 and the Price/Book (PB) ratio is 1.73.


Can you provide the dividend sustainability for HSTM stock?

The dividend rating of HEALTHSTREAM INC (HSTM) is 4 / 10 and the dividend payout ratio is 20.33%.